Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has become one of the most studied medications for weight management, with clinical trials showing an average weight reduction of 10–15% when combined with lifestyle changes. However, the question most patients ask is simple: how much weight will *I* personally lose? The answer depends on several factors beyond the medication itself, including your starting weight, genetic response patterns, and commitment to diet and exercise.
Average Semaglutide Weight Loss in Clinical Trials
The landmark STEP clinical trials tracked thousands of patients taking semaglutide over 68 weeks alongside calorie restriction and physical activity. Participants receiving the highest dose lost an average of 15.3% of their body weight, compared to 2.6% in the placebo group. A patient starting at 250 pounds might expect to lose 35–40 pounds on an effective dose, though individual variation is substantial.
Weight loss typically accelerates after the first 4–6 weeks as your body adjusts to the medication and appetite suppression deepens. Most patients experience the steepest decline between months 2 and 4, then reach a stable plateau by month 5 or 6. Importantly, continued adherence to diet and exercise throughout this period significantly amplifies results—patients who engage in regular physical activity lose 2–3 pounds more per month than sedentary users.
Factors That Influence Your Personal Weight Loss
Not everyone loses weight at the same rate on semaglutide, even at identical doses. Your baseline metabolic rate, insulin sensitivity, age, and hormonal balance all play a role. Starting weight matters too: a patient with severe obesity may lose more total pounds than someone with mild overweight, though percentage-based loss can be similar. Genetics also determines how efficiently your body responds to GLP-1 receptor activation, which is why some individuals see dramatic results within weeks while others achieve meaningful loss more gradually.
Lifestyle choices compound medication effects. Patients who reduce refined carbohydrates, increase protein intake, and move their body for at least 150 minutes per week consistently outperform those relying on semaglutide alone. Sleep quality, stress management, and hydration status influence weight loss velocity as well. PlexusDx's Precision Peptide Genetic Test identifies your unique peptide-pathway variants—including GLP1R and GIPR markers—to predict which dose range and formulation will match your genetic predisposition for optimal response.
Semaglutide Dose and Weight Loss Progression
Semaglutide doses start low (usually 0.25 mg weekly) and increase gradually every 4 weeks to minimize nausea and allow your body to adapt. Your dose may need to go up. Your price won't—PlexusDx charges one flat monthly rate for Compounded Semaglutide Injection starting at $149, regardless of your dose level. Most patients reach therapeutic doses (1.0–2.4 mg weekly) by week 12, where weight loss becomes most pronounced and consistent.
Some patients achieve their target weight on lower maintenance doses, while others require the full dose range to see meaningful change. There is no universal 'best dose'—your prescriber will adjust based on your tolerance, side effects, and progress. Genetic factors influence dose responsiveness; the PlexusDx Precision Peptide Genetic Test screens variants in GLP1R (rs6923761) and GIPR (rs1800437) that affect receptor sensitivity and predict which dose tier your body will respond to most effectively.
Realistic Timelines for Semaglutide Weight Loss Results
Week 1–4: Most patients notice reduced appetite and cravings within the first 7–10 days. Actual weight loss is typically modest (1–3 pounds), partly from reduced calorie intake and partly from water loss. Nausea and mild gastrointestinal adjustment are common and usually resolve by week 3.
Weeks 4–12: As your dose increases and your body adapts, weight loss accelerates. Expect 1–3 pounds per week during this phase if you maintain consistent diet and exercise. This is when most people feel the medication 'click'—appetite suppression becomes profound, and food choices naturally shift toward protein and vegetables.
Months 4–6: Weight loss typically plateaus at a sustainable rate of 1–2 pounds per week. By month 6, you will have achieved most of your total loss; further progress slows but continues. Some patients report a 'whoosh' effect where weight drops suddenly after a plateau week, driven by metabolic shifts and reduced water retention.
When to Expect a Weight Loss Plateau
A weight loss plateau—a period of 2–4 weeks with no scale movement—is entirely normal and does not mean the medication has stopped working. Plateaus occur because your body adapts to calorie restriction and reaches a new baseline metabolic rate. Many patients experience 2–3 short plateaus over six months; they typically resolve with no intervention beyond patience and consistency.
If you reach a plateau and want to break through it, strategies include increasing exercise intensity, reducing calorie intake slightly under your prescriber's guidance, or increasing semaglutide dose at your next adjustment window. Genetic testing through PlexusDx's Precision Peptide Genetic Test can reveal whether genetic variants in FTO (rs9939609) or MC4R (rs17782313)—markers linked to appetite regulation and weight gain—are influencing your plateau and whether dual-peptide therapy (GLP-Squared) might unlock better results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight will I lose in the first month on semaglutide?
Most patients lose 3–8 pounds in month one, driven largely by reduced appetite and calorie intake rather than metabolic effects. Nausea and dose adjustments during week 1–4 may slow initial loss. By month two, as your dose stabilizes, weight loss accelerates to 1–3 pounds per week in most users.
Is 15% weight loss typical, or can I expect more?
In STEP trials, the average patient on semaglutide lost 10–15% of body weight over 68 weeks. Some achieved 22% loss, and others achieved 5–10%. Results depend on dose, adherence, starting weight, and genetics. PlexusDx's genetic test identifies peptide-pathway variants that influence your personal response ceiling.
Does compounded semaglutide from PlexusDx produce the same weight loss as brand-name Ozempic?
PlexusDx's Compounded Semaglutide Injection is manufactured by licensed 503A compounding pharmacies and contains identical active ingredient to brand medications. Weight loss results depend on dose consistency, adherence, and individual biology—not source. PlexusDx charges one flat rate ($149/mo start) regardless of dose, making consistent therapy more affordable.
What if I don't lose weight on semaglutide?
Rare, but possible. Non-response may indicate suboptimal dosing, poor medication adherence, genetic resistance, or underlying metabolic conditions. PlexusDx offers the Precision Peptide Genetic Test after your first month to identify GLP1R and GIPR variants that predict response. If semaglutide underperforms, GLP-Squared (dual compound) or oral formulations may work better for your genetics.
How does the PlexusDx Precision Peptide Genetic Test help predict my weight loss?
The $99 add-on test (available after month one) screens 14 peptide pathways, 49 peptides, and 150+ genetic insights, including variants in GLP1R, GIPR, FTO, and MC4R that influence appetite regulation and weight loss responsiveness. Results guide dose optimization and inform whether dual-peptide therapy (like GLP-Squared) may unlock better results for your unique biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding What Happens When You Increase Tirzepatide Dose
How Often Can You Take Semaglutide for Weight Loss?